Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
Jaissle GB, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Heimann H, Meyer CH; Retinal Vein Occlusion Study Group. Jaissle GB, et al. Among authors: feltgen n. Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):183-92. doi: 10.1007/s00417-010-1470-2. Epub 2010 Aug 18. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21337042 Free PMC article.
Early REperfusion Therapy with Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion (REVISION): Study Protocol of a Phase III Trial.
Poli S, Grohmann C, Wenzel DA, Poli K, Tuennerhoff J, Nedelmann M, Fiehler J, Agostini H, Campbell B, Fischer DM, Sykora M, Mac Grory B, Feltgen N, Seiffge DJ, Strbian D, Schultheiß M, Spitzer MS. Poli S, et al. Among authors: feltgen n. Int J Stroke. 2024 Apr 9:17474930241248516. doi: 10.1177/17474930241248516. Online ahead of print. Int J Stroke. 2024. PMID: 38591748
Central retinal artery occlusion - detection score.
Casagrande M, Steinhorst NA, Dippel SK, Kück F, Grohmann C, Spitzer MS, Poli S, Feltgen N, Schultheiss M. Casagrande M, et al. Among authors: feltgen n. Front Med (Lausanne). 2023 Mar 1;10:1129002. doi: 10.3389/fmed.2023.1129002. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36936219 Free PMC article.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Intravitreal Injections: Improving Sustainability by Reducing Clinical Waste.
Birtel J, Hammer M, Feltgen N, Pauleikhoff L, Ong AY, Geerling G, Spitzer MS, Charbel Issa P. Birtel J, et al. Among authors: feltgen n. Klin Monbl Augenheilkd. 2024 Apr 4. doi: 10.1055/a-2184-9492. Online ahead of print. Klin Monbl Augenheilkd. 2024. PMID: 38574679 English, German.
234 results